Accrete-D3

The least expensive calcium + vitamin D3 brand offering a choice of swallowable and chewable tablets1,2

Non-adherence to osteoporosis therapy places a huge burden on healthcare systems; the cost/patient is six times higher than with diabetes medication.3 Flavour, texture, and pill burden can impact on adherence.4

Accrete is Indicated for the prevention and treatment of vitamin D and calcium deficiency in the elderly. Adjunct to specific osteoporosis treatment for patients at risk of vitamin D and calcium deficiency.5,6

Accrete Prescribing Information

Respecting patient preference is an important way to support treatment persistence.7

With Accrete-D3, patients at risk of calcium and vitamin D3 deficiency have a choice:

Twice-daily, film-coated, swallowable tablets5
OR…
Once-daily, orange-flavoured, chewable tablets6
The cost of either treatment option is just £2.95 for 30 days, this is equivalent to approximately £35.89 per year.2,8
Provides savings of up to 37% vs Adcal-D3® Chewable Tablets (56 pack)2,5,6,9-11

During pregnancy, daily dose should not exceed 1500 mg calcium and 600 IU vitamin D. See SmPC for more information.

Request Cost
Savings Report

Accrete is the least expensive calcium + vitamin D3 brand offering a choice of swallowable and chewable tablets.1,2

Please complete this form and a member of our team will contact you with specific cost-savings information for your locality.

Register for cost savings

Patient Guide download

Please register for an instant download of the Accrete patient guide for more information on the importance of a calcium-vitamin D treatment and tips on how to improve bone health alongside the treatment.

Register to download

References

  1. NHS List Price, Drug Tariff. Last accessed June 2024.
  2. DM+D. Available at: services.nhsbsa.nhs.uk/dmd-browser. Last accessed June 2024.
  3. Cutler RL et al. BMJ Open 2018; 8(1): e016982.
  4. Shariff Z et al. Pharmaceutics 2020; 12(10): 905.
  5. Accrete D3 Film-Coated Tablets Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/2766. Last accessed June 2024.
  6. Accrete D3 One a Day 1000 mg / 880 IU Chewable Tablets Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/8506. Last accessed June 2024.
  7. Martin LR et al. Ther Clin Risk Manag 2005 Sep;1(3):189-99.
  8. One year comparable price = pack cost / number of days treatment per pack * 365 (rounded to the nearest penny).
  9. NHS prescribing data (NHS Prescribing Data – AH: Showing Oct 2022 to Sept 2023 data for UK excluding Scotland. Showing Aug 2022 to July 2023 for Scotland). Comparable Accrete Spend prices are taken from DM+D. Available at https://services.nhsbsa.nhs.uk/dmd-browser. Last accessed June 2024, based on Accrete List Price. Comparable Accrete spend = units prescribed * 30 day comparable price. 30 day comparable price = pack cost / number of days treatment per pack * 30 (rounded to the nearest penny).
  10. Savings of up to 37% with Accrete-D3 One a Day (1000mg/880IU) chewable tablets at £2.95 for 30 tablets vs Adcal-D3 (600mg/400IU) twice daily chewable tablets at £4.69, this is an equivalent cost for 30 days treatment. Adcal-D3 (600mg/400IU) twice daily chewable tablets are listed at £4.38 for 56 tablets.
  11. Adcal-D3® Chewable Tablets. Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/1356/smpc. Last accessed June 2024.

Adcal-D3® is a registered trademark of Kyowa Kirin Services Ltd.

Information

For information on our products please visit EMC, https://www.medicines.org.uk/emc/ and search the product for a Summary of Product Characteristics

Adverse events should be reported to Thornton and Ross Limited by emailing thorntonross@medinformation.co.uk or by calling 01484 848164. Additionally, reporting forms and information can be found at: https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store.

UK-MULT-130a(3) | June 2024

This site is intended to provide information to Healthcare Professionals on Thornton & Ross products.

I am a Healthcare Professional

Yes    No

The information on our Healthcare Professional Website is solely intended for UK Healthcare Professionals and contains promotional information. Click here to return to our main public site.

For information on our products please visit EMC, and search the product for a Summary of Product Characteristics

Adverse events should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Thornton and Ross Limited by emailing thorntonross@medinformation.co.uk or by calling 01484 848164

You Are Now Leaving This Website

The website you are going to is maintained by a third party over whom Thornton & Ross Limited has no control or responsibility. We have provided this link as an appropriate resource to our visitors but Thornton & Ross Limited is not responsible for the content or information on this site.

Continue to site

UK-STADA-323   |   Date of Preparation November 2023